agilon health (AGL) Proxy Filing summary

Executive summary

• A special meeting of stockholders is scheduled for March 17, 2026, to vote on a key proposal regarding a reverse stock split.

• A supplement corrects the number of shares potentially outstanding post-split to a range between 16,594,791 and 82,973,952, replacing a previously stated higher figure.

• The supplement clarifies that all other information and board recommendations remain unchanged.

Voting matters and shareholder proposals

• Proposal No. 1 seeks approval to amend the certificate of incorporation to effect a reverse stock split, with a split ratio range of 5-to-1 up to 25-to-1.

• The reverse stock split would reduce outstanding shares from about 414,869,759 to between 16,594,791 and 82,973,952, depending on the final ratio.

• The board does not intend to effectuate the split if it would result in delisting from the NYSE or the company going private.

Board of directors and corporate governance

• The board retains discretion to determine the final split ratio and whether to implement the reverse stock split.